Publications (113) Luis Miguel Seijo Maceiras publications

filter_list

2025

  1. Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer

    European Journal of Cancer, Vol. 220

  2. Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain

    Journal of Medical Economics, Vol. 28, Núm. 1, pp. 147-156

  3. Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data

    Cancer Immunology, Immunotherapy, Vol. 74, Núm. 4

2024

  1. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  2. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

    ERJ Open Research, Vol. 10, Núm. 2

  3. Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial

    Journal of Clinical Medicine, Vol. 13, Núm. 17

  4. Diagnóstico precoz de cáncer de pulmón en muestras de suero previas a su diagnóstico clínico: Utilidad de la metabolómica

    Revista española de patología torácica, Vol. 36, Núm. 2, pp. 127-140

  5. First Ibero-American Summit on Lung Cancer Screening

    Archivos de Bronconeumologia

  6. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  7. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  8. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  9. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  10. Probabilidad de malignidad de los nódulos pulmonares incidentales según la “mayo lung calculator” y un kit de 6 biomarcadores proteicos

    Revista española de patología torácica, Vol. 36, Núm. 1, pp. 61-61

  11. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

    Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490

  12. Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

    Archivos de Bronconeumologia, Vol. 60, pp. S67-S76

  13. Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer

    ERJ Open Research, Vol. 10, Núm. 1

  14. The tip of the iceberg: a plethora of lung nodules in the general population

    The European respiratory journal

  15. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

    Radiology, Vol. 309, Núm. 2, pp. e231988

  2. Cambios en el perfil metabolómico en suero tras la cirugía curativa del cáncer de pulmón. Estudio PROMOTER

    Revista española de patología torácica, Vol. 35, Núm. 1, pp. 43-44